Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial

Author's Avatar
Aug 03, 2020
Article's Main Image

- I-SPY COVID will evaluate the impact of cenicriviroc, Otezla®, and Firazyr® on inflammatory response in COVID-19 patients

- Additional candidates from COVID R&D member companies entering platform trials in coming weeks

PR Newswire